Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: Treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group

Journal of Clinical Oncology

Volumn 21, Issue 9, 2003, Pages 1782-1789

  Seidemann, K ^a   Tiemann, M ^a   Lauterbach, I ^a   Mann, G ^a   Simonitsch, I ^a   Stankewitz, K ^a   Schrappe, M ^a   Zimmermann, M ^a   Niemeyer, C ^a   Parwaresch, R ^a   Riehm, H ^a   Reiter, Alfred ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; METHOTREXATE; OXAZAPHOSPHORINE DERIVATIVE; STEROID; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; TUMOR MARKER;

ADOLESCENT; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DRUG MEGADOSE; FEMALE; GERMANY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MEDICAL SOCIETY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SCLEROSIS; T CELL LYMPHOMA; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; DISEASE COURSE; DISEASE FREE SURVIVAL; FOLLOW UP; HISTIOCYTIC LYMPHOMA; INFANT; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYTARABINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; L-LACTATE DEHYDROGENASE; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; METHOTREXATE; PROGNOSIS; SCLEROSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0038134990     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.08.151     Document Type: Article

References (37)

1. Addis BJ, Isaacson PG: Large cell lymphoma of the mediastinum: A B-cell tumour of probable thymic origin. Histopathology 10:379-390, 1986
2. Miller JB, Variakojis D, Bitran JD, et al: Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction. Cancer 47:748-756, 1981
3. Menestrina F, Chilosi M, Bonetti F, et al: Mediastinal large cell lymphoma of B-cell origin with sclerosis: Histopathological and immunohistochemical study of eight cases. Histopathology 10:589-600, 1986
4. Kanavaros P, Gaulard P, Charlotte F, et al: Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B-cell lymphomas. Am J Pathol 146:735-741, 1995
5. Abou-Elella AA, Weisenburger D, Vose J, et al: Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol 17:784-790, 1999
6. Todeschini G, Ambrosetti A, Meneghini V, et al: Mediastinal large B-cell lymphoma with sclerosis: A clinical study of 21 patients. J Clin Oncol 8:804-808, 1990
7. Falini B, Venturi S, Martelli M, et al: Mediastinal large B-cell lymphoma: Clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 89:780-789, 1995
8. Perrone T, Frizzera G, Rosai J: Mediastinal diffuse large-cell lymphoma with sclerosis: A clinicopathologic study of 60 cases. Am J Surg Pathol 10:176-191, 1986
9. Rohatiner AZS, Whelan JS, Ganjoo RK, et al: Mediastinal large-cell lymphoma with sclerosis (MLCLS). Br J Cancer 69:601-604, 1994
10. Cazals-Hatem D, Lepage E, Brice P, et al: Primary mediastinal large B-cell lymphoma. Am J Surg Pathol 20:877-888, 1996
11. Martelli MP, Martelli M, Pescarmona E, et al: MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol 9:1027-1029, 1998
12. 67gallium scan in 50 patients. Blood 94:3289-3293, 1999
13. Carr TF, Lockwood L, Stevens RF, et al: Childhood B cell lymphomas arising in the mediastinum. J Clin Pathol 46:513-516, 1993
14. Piira T, Perkins SL, Anderson JR, et al: Primary mediastinal large cell lymphoma in children: A report from the Children's Cancer Group. Pediatr Pathol Lab Med 15:561-570, 1995
15. Wright D, McKeever P, Carter R: Childhood non Hodgkin lymphomas in the United Kingdom: Findings from the UK Children's Cancer Study Group. J Clin Pathol 50:128-134, 1997
16. Jaffe ES, Harris NL, Stein H, et al (eds): Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours. Lyon, France, IARC Press, 2001
17. Stansfeld AG, Diebold J, Kapanci Y, et al: Updated Kiel classification for lymphomas. Lancet 13:292-293, 1988
18. Mason DY, Cordell J, Brown M, et al: Detection of T-cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol 42:1194-1200, 1989
19. Hansmann ML, Wacker HH, Gralla J, et al: KiBS: A monoclonal antibody unrelated to CD45 recognizes normal and neoplastic B-cells in routine paraffin sections. Blood 77:809-817, 1991
20. Schwarting R, Gerdes J, Durkop H, et al: BerH2: A new anti-Kil (CD30) monoclonal antibody directed at a formalin-resistant epitope. Blood 74:1678-1689, 1989
21. Murphy SB: Classification, staging and end results of treatment in childhood non-Hodgkin's lymphoma: Dissimilarities from lymphomas in adults. Semin Oncol 7:332-339, 1980
22. Lister TA, Crowther D, Sutcliffe SB: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630-1636, 1989
23. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage-A report of the Berlin-Frankfurt-Münster Group. J Clin Oncol 13:359-372, 1995
24. Reiter A, Schrappe M, Tiemann M, et al: Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster group trial NHL-BFM 90. Blood 94:3294-3306, 1999
25. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
26. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
27. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
28. Greenwood M: A report on the natural duration of cancer. Reports on public health and statistical subjects, No. 33, Appendix 1. The errors of sampling of the survivorship tables. London, United Kingdom, HM Stationery Office, 1926, pp 1-26
29. Patte C, Auperin A, Michon J, et al: The Société Francaise d'Oncologie Pédiatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97:3370-3379, 2001
30. Lones MA, Perkins SL, Sposto R, et al: Large cell lymphoma arising in the mediastinum in children and adolescents is associated with an excellent outcome: A Children's Cancer Group report. J Clin Oncol 18:3845-3853, 2000
31. Kaatsch P, Spix C, Michaelis J: 20 years German Childhood Cancer Registry-Annual Report 1999. Mainz, Germany, Druckbetrieb Lindner OHG, 2000
32. Bishop PC, Wilson WH, Pearson D, et al: CNS involvement in primary mediastinal large B-cell lymphoma. J Clin Oncol 17:2479-2485, 1999
33. Seidemann K, Meyer U, Jansen P, et al: Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Klin Padiatr 210:279-284, 1998
34. Hande KR, Garrow GC: Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am J Med 94:133-139, 1993
35. Bieri S, Roggiero E, Zucco E, et al: Primary mediastinal large B-cell lymphoma (PMLCL): The need for prospective controlled clinical trials. Leuk Lymphoma 35:139-146, 1999
36. Popat U, Przepiork D, Champlin R, et al: High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome. J Clin Oncol 16:63-69, 1998
37. Ingram L, Mott MG, Mann JR, et al: Second malignancies in children treated for non-Hodgkin lymphoma and T-cell leukaemia with the UKCCSG regimens. Br J Cancer 55:463-466, 1987